CD8+ T effector memory cells protect against liver-stage malaria

Identification of correlates of protection for infectious diseases including malaria is a major challenge and has become one of the main obstacles in developing effective vaccines.We investigated protection against liver-stage malaria conferred by vaccination with adenoviral (Ad) and modified vaccin...

Full description

Bibliographic Details
Main Authors: Reyes-Sandoval, A, Wyllie, D, Bauza, K, Milicic, A, Forbes, E, Rollier, C, Hill, A
Format: Journal article
Language:English
Published: 2011
_version_ 1826297047769153536
author Reyes-Sandoval, A
Wyllie, D
Bauza, K
Milicic, A
Forbes, E
Rollier, C
Hill, A
author_facet Reyes-Sandoval, A
Wyllie, D
Bauza, K
Milicic, A
Forbes, E
Rollier, C
Hill, A
author_sort Reyes-Sandoval, A
collection OXFORD
description Identification of correlates of protection for infectious diseases including malaria is a major challenge and has become one of the main obstacles in developing effective vaccines.We investigated protection against liver-stage malaria conferred by vaccination with adenoviral (Ad) and modified vaccinia Ankara (MVA) vectors expressing pre-erythrocytic malaria Ags. By classifying CD8+ T cells into effector, effector memory (TEM), and central memory subsets using CD62L and CD127 markers, we found striking differences in T cell memory generation. Although MVA induced accelerated central memory T cell generation, which could be efficiently boosted by subsequent Ad administration, it failed to protect against malaria. In contrast, Ad vectors, which permit persistent Ag delivery, elicit a prolonged effector T cell and TEM response that requires long intervals for an efficient boost. A preferential TEM phenotype was maintained in liver, blood, and spleen after Ad/MVA prime-boost regimens, and animals were protected against malaria sporozoite challenge. Blood CD8+ TEM cells correlated with protection against malaria liver-stage infection, assessed by estimation of number of parasites emerging from the liver into the blood. The protective ability of Agspecific TEM cells was confirmed by transfer experiments into naive recipient mice. Thus, we identify persistent CD8 TEMpopulations as essential for vaccine-induced pre-erythrocytic protection against malaria, a finding that has important implications for vaccine design. Copyright © 2011 by The American Association of Immunologists, Inc.
first_indexed 2024-03-07T04:25:40Z
format Journal article
id oxford-uuid:cc84a91e-c13c-43b7-b169-b8deec8200dd
institution University of Oxford
language English
last_indexed 2024-03-07T04:25:40Z
publishDate 2011
record_format dspace
spelling oxford-uuid:cc84a91e-c13c-43b7-b169-b8deec8200dd2022-03-27T07:22:37ZCD8+ T effector memory cells protect against liver-stage malariaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cc84a91e-c13c-43b7-b169-b8deec8200ddEnglishSymplectic Elements at Oxford2011Reyes-Sandoval, AWyllie, DBauza, KMilicic, AForbes, ERollier, CHill, AIdentification of correlates of protection for infectious diseases including malaria is a major challenge and has become one of the main obstacles in developing effective vaccines.We investigated protection against liver-stage malaria conferred by vaccination with adenoviral (Ad) and modified vaccinia Ankara (MVA) vectors expressing pre-erythrocytic malaria Ags. By classifying CD8+ T cells into effector, effector memory (TEM), and central memory subsets using CD62L and CD127 markers, we found striking differences in T cell memory generation. Although MVA induced accelerated central memory T cell generation, which could be efficiently boosted by subsequent Ad administration, it failed to protect against malaria. In contrast, Ad vectors, which permit persistent Ag delivery, elicit a prolonged effector T cell and TEM response that requires long intervals for an efficient boost. A preferential TEM phenotype was maintained in liver, blood, and spleen after Ad/MVA prime-boost regimens, and animals were protected against malaria sporozoite challenge. Blood CD8+ TEM cells correlated with protection against malaria liver-stage infection, assessed by estimation of number of parasites emerging from the liver into the blood. The protective ability of Agspecific TEM cells was confirmed by transfer experiments into naive recipient mice. Thus, we identify persistent CD8 TEMpopulations as essential for vaccine-induced pre-erythrocytic protection against malaria, a finding that has important implications for vaccine design. Copyright © 2011 by The American Association of Immunologists, Inc.
spellingShingle Reyes-Sandoval, A
Wyllie, D
Bauza, K
Milicic, A
Forbes, E
Rollier, C
Hill, A
CD8+ T effector memory cells protect against liver-stage malaria
title CD8+ T effector memory cells protect against liver-stage malaria
title_full CD8+ T effector memory cells protect against liver-stage malaria
title_fullStr CD8+ T effector memory cells protect against liver-stage malaria
title_full_unstemmed CD8+ T effector memory cells protect against liver-stage malaria
title_short CD8+ T effector memory cells protect against liver-stage malaria
title_sort cd8 t effector memory cells protect against liver stage malaria
work_keys_str_mv AT reyessandovala cd8teffectormemorycellsprotectagainstliverstagemalaria
AT wyllied cd8teffectormemorycellsprotectagainstliverstagemalaria
AT bauzak cd8teffectormemorycellsprotectagainstliverstagemalaria
AT milicica cd8teffectormemorycellsprotectagainstliverstagemalaria
AT forbese cd8teffectormemorycellsprotectagainstliverstagemalaria
AT rollierc cd8teffectormemorycellsprotectagainstliverstagemalaria
AT hilla cd8teffectormemorycellsprotectagainstliverstagemalaria